The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy
Related Experiment Video
Updated: Dec 23, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Umberto Maggi1, Luciano De Carlis2, Daniel Yiu3
1General Surgery and Liver Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Insights
Liver transplantation (LT) programs faced challenges during the COVID-19 pandemic. Despite a decrease in donors and one COVID-19-related death, LT recipients showed no specific safety concerns, suggesting program continuation is viable.
Area of Science:
- Medicine
- Virology
- Transplant Surgery
Background:
- The COVID-19 pandemic caused significant disruption to healthcare systems globally, including liver transplantation (LT).
- Lombardy, Italy, was severely impacted, with a high COVID-19 mortality rate and increased ICU bed demand.
- A notable decrease in liver donor availability was observed during the pandemic.
Purpose of the Study:
- To evaluate the safety and feasibility of continuing liver transplantation (LT) programs during the COVID-19 pandemic.
- To report on the outcomes of LT procedures performed in a highly affected region.
- To identify key lessons learned from managing LT during a viral outbreak.
Main Methods:
- Retrospective analysis of 17 liver transplantation (LT) procedures performed in Lombardy between February 23rd and April 10th.
- Screening of all donors for SARS-CoV-2 prior to LT.
- Monitoring of recipient outcomes, including post-transplant SARS-CoV-2 status and survival rates.
Main Results:
- Seventeen liver transplantations (LTs) were performed with a mean donor age of 49 and recipient age of 55.
- Two recipients tested positive for SARS-CoV-2 post-LT, and one patient died on post-operative day 30 due to COVID-19.
- Sixteen patients survived an average of 30 days post-LT, with 10 discharged, indicating no specific recipient safety concerns.
Conclusions:
- No specific safety concerns for recipients necessitate the complete cessation of liver transplantation (LT) programs during the pandemic.
- While continuation is possible, a reduction in LT activity may be a pragmatic approach due to the complex circumstances of the viral outbreak.
- Experience gained provides valuable lessons for managing LT in future infectious disease crises.
Abstract:
In January 2020, Novel Coronavirus Disease 2019 (COVID-19) resulted in a global pandemic, creating uncertainty toward the management of liver transplantation (LT) programs. Lombardy has been the most affected region in Italy: the current mortality rate of COVID-19 patients is 18.3% (10 022 deaths; April 10th) with hospitals in Lombardy having to expand the total number of ICU beds from 724 to 1381 to accommodate infected patients. There has been a drastic decrease in liver donors. From February 23rd until April 10th, 17 LTs were performed in Lombardy. Mean donor age was 49 years (range 18-74) whereas mean recipient age was 55 (13-69); mean MELD score was 12 (6-24). All donors underwent screening for SARS-CoV-2 prior to LT. Two patients tested positive after LT, and one patient died for COVID on POD 30. Sixteen patients are alive after an average of 30 days post-LT (range 3-46). 10 patients have been discharged. This study has found no specific reason concerning the safety of recipients, to stop LT programs. Several key lessons from our experience are reported. However, due to the complex circumstances which surround the viral outbreak, the cessation or a reduction in LT activity is a pragmatic requirement.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

